| Mr Jose A Marques Bibiloni Sr, MD | |
|
Manuel Pavia Fernandez 655 4th Piso, Santurce, PR 00909 | |
| (787) 728-2479 | |
| (787) 786-7447 |
| Full Name | Mr Jose A Marques Bibiloni Sr |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Hematology & Oncology |
| Location | Manuel Pavia Fernandez 655 4th Piso, Santurce, Puerto Rico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033101068 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 10042 (Puerto Rico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Jose A Marques Bibiloni Sr, MD Po Box 19798, San Juan, PR 00910-1798 Ph: (787) 728-2479 | Mr Jose A Marques Bibiloni Sr, MD Manuel Pavia Fernandez 655 4th Piso, Santurce, PR 00909 Ph: (787) 728-2479 |
News Archive
VIVUS, Inc. today announced that a New Drug Application (NDA) has been submitted to the U.S. Food and Drug Administration (FDA) seeking approval of avanafil, its investigational drug for the treatment of erectile dysfunction.
DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced its operating results for the third quarter of 2010: $1.8 million revenue, $11.4 million backlog, and continued profitability, resulting in a cash increase over second quarter 2010.
Bristol-Myers Squibb Company today announced the full results, published in the New England Journal of Medicine, from a Phase II clinical trial in patients with hepatitis C virus (HCV) genotype 1 who had not responded to prior therapy with PEG-interferon alfa and ribavirin ('null responders').
Palatin Technologies, Inc. announced today that enrollment of patients has commenced in Palatin's Phase 2b clinical trial evaluating the efficacy and safety of bremelanotide (previously called PT-141), an on-demand, first-in-class melanocortin agonist being developed for the treatment of female sexual dysfunction (FSD).
New research published in the International Journal of Toxicology (IJT) by Gary S. Goldman, Ph.D., reveals high rates of shingles (herpes zoster) in Americans since the government's 1995 recommendation that all children receive chicken pox vaccine.
› Verified 4 days ago
Dr. Edwin E Pagan Lopez, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 803 Ave Hipodromo, Santurce, PR 00909 Phone: 787-724-3734 Fax: 787-724-1322 | |
Dr. Jaime Martinez-souss, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 328 De Diego Ave, Suite 202 Ponce De Leon Ave., Santurce, PR 00909 Phone: 787-723-9025 Fax: 787-722-1987 | |
Dr. Carlos Ruben Diaz, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1449 Calle Americo Salas, Edificio Pavia Ii, Suite 102, Santurce, PR 00909 Phone: 787-721-0525 Fax: 787-722-1225 | |
Dr. Wanda Ramos, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 359 Ave De Diego 501, Santurce, PR 00909 Phone: 787-722-0445 Fax: 787-723-4415 | |
Dr. Jose R Nadal, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1400 Calle San Rafael, Suite 201, Santurce, PR 00909 Phone: 787-721-6626 Fax: 787-725-1287 | |
Dr. Maria E. Narvaez Rivera, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1801 Ave Ponce De Leon, Santurce Medical Mall Suite 206, Santurce, PR 00909 Phone: 787-268-4333 Fax: 787-728-4163 |